↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

887 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (-)-3-(4-aminophenyl)-2-methoxypropionic acid   -   -   -   -   1件:
97 
 2   (r)-3-(1-oxo-propoxy)-4-(n,n,n-trimethyl amonium chloride)-butanoic acid   Butyric Acid, Chloride ion   D05866   -   -   1件:
97 
 3   (s)-(-)-3-(4-aminophenyl)-2-methoxypropionic acid   -   -   -   -   1件:
97 
 4   (s)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile hydrochloride   -   -   -   -   1件:
97 
 5   -aminosalicylic acid   Aminosalicylic Acid   D00162   -   -   2件:
96,
97 
 6   0.25 mg rpc1063   -   -   -   -   2件:
96,
97 
 7   0.25mg rpc103   -   -   -   -   1件:
97 
 8   0.5 mg rpc1063   -   -   -   -   1件:
97 
 9   1 mg rpc1063   -   -   -   -   1件:
97 
 10   1.0 mg rpc103   -   -   -   -   1件:
97 
 11   1.0 mg rpc1063   -   -   -   -   1件:
97 
 12   1.remicade   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 13   10 mg natura-alpha capsule   -   -   -   -   1件:
97 
 14   100 mg   -   -   -   -   1件:
97 
 15   150 mg   -   -   -   -   1件:
97 
 16   1500mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 17   15n2-tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   34件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   1件:
97 
 18   2 x 10 mg natura-alpha capsules   -   -   -   -   1件:
97 
 19   2'-fucosyllactose   -   -   -   -   2件:
96,
97 
 20   2-hydroxybenzoic acid   Salicylic acid   D00097   -   -   1件:
97 
 21   20 mg   -   -   -   -   1件:
97 
 22   225mg pf-00547659   -   -   -   -   1件:
97 
 23   23-valent polysaccharide pneumococcal vaccine (pneumovax tm)   -   -   -   -   2件:
96,
97 
 24   250mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 25   2l polyethylene glycol/ascorbic acid   Ascorbic acid, Polyethylene glycol   D00018, D03370   -   -   1件:
97 
 26   331731-18-1   -   -   -   -   2件:
46,
97 
 27   40 mg msb11022   -   -   -   -   4件:
46,
96,
97,
271 
 28   42942019   -   -   -   -   4件:
46,
96,
97,
271 
 29   450 mg   -   -   -   -   1件:
97 
 30   5 asa   Mesalazine   D00377   -   -   1件:
97 
 31   5 asa, enemas, suppositories, corticosteroids   Mesalazine   D00377   -   -   1件:
97 
 32   5-amino salicylic acid   Salicylic acid   D00097   -   -   1件:
97 
 33   5-amino salicylic acid (5-asa)   Mesalazine, Salicylic acid   D00097, D00377   -   -   1件:
97 
 34   5-amino-2-hydroxybenzoic acid   Salicylic acid   D00097   -   -   1件:
97 
 35   5-aminosalicyclic acid   -   -   -   -   1件:
97 
 36   5-aminosalicylate   5-aminosalicylate   D00377   -   -   2件:
96,
97 
 37   5-aminosalicylate (pentasa, ferring)   5-aminosalicylate, Mesalazine   D00377   -   -   2件:
96,
97 
 38   5-aminosalicylic acid   Mesalazine, Aminosalicylic Acid   D00162, D00377   -   -   2件:
96,
97 
 39   5-aminosalicylic acid (5-asa)   Mesalazine, Aminosalicylic Acid   D00162, D00377   -   -   1件:
97 
 40   5-aminosalicylic acid(5-asa) and/or prednisone   Mesalazine, Aminosalicylic Acid, Ethanol   D00068, D00162, D00377, D02798, D04855, D06542   -   -   1件:
97 
 41   5-asa   Mesalazine   D00377   -   -   2件:
96,
97 
 42   5-asa (5-aminosalicylate)   Mesalazine, 5-aminosalicylate   D00377   -   -   1件:
97 
 43   5-asa mmx   Mesalazine   D00377   -   -   1件:
97 
 44   5-htp   -   -   -   -   2件:
96,
97 
 45   50 mg   -   -   -   -   1件:
97 
 46   500 mg lx1606 qd   -   -   -   -   1件:
97 
 47   500 mg lx1606 tid   -   -   -   -   1件:
97 
 48   500mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 49   549-0261/f02-01   -   -   -   -   2件:
96,
97 
 50   5asa   Mesalazine   D00377   -   -   1件:
97 
 51   6 mercaptopurine   Mercaptopurine, 6 mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 52   6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid   -   -   -   -   1件:
97 
 53   6-mercaptopurine   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
97,
164 
 54   6-mp   Mercaptopurine   D00161, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 55   750mg mesalazine pellets   Mesalazine   D00377   -   -   1件:
97 
 56   75mg pf-00547659   -   -   -   -   1件:
97 
 57   [124i]ib pf 06687234   -   -   -   -   1件:
97 
 58   [14c]-rpc1063 solution (0.1 mg/ml) for oral administration   -   -   -   -   3件:
13,
96,
97 
 59   [18f]fspg   -   -   -   -   2件:
96,
97 
 60   A multistrain probiotic product (dsf)   -   -   -   -   1件:
97 
 61   A: 1 dosis   -   -   -   -   1件:
97 
 62   Ab (antibiotics)   -   -   -   -   1件:
97 
 63   Abalimumab   -   -   -   -   1件:
97 
 64   Abatacept   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 65   Abatacept (aba)   Abatacept   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   1件:
97 
 66   Abbv-006   -   -   -   -   1件:
97 
 67   Abbv-066   -   -   -   -   2件:
96,
97 
 68   Abbv-323 dose a   -   -   -   -   1件:
97 
 69   Abbv-323 dose b   -   -   -   -   1件:
97 
 70   Abgn-168h   -   -   -   -   1件:
97 
 71   Abi-m201   -   -   -   -   1件:
97 
 72   Abt-494   -   -   -   -   3件:
46,
96,
97 
 73   Abx464   ABX464   -   -   -   3件:
46,
96,
97 
 74   Abx464 100mg   ABX464   -   -   -   2件:
46,
97 
 75   Abx464 25mg   ABX464   -   -   -   1件:
97 
 76   Abx464 50mg   ABX464   -   -   -   2件:
46,
97 
 77   Accelerated 1 hour-infusion   -   -   -   -   2件:
96,
97 
 78   Accelerated 30 minutes-infusion   -   -   -   -   2件:
96,
97 
 79   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 80   Acetic acid   Acetic acid   D00010   -   -   1件:
97 
 81   Active group   -   -   -   -   1件:
97 
 82   Adalimumab   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 83   Adipose tissue-derived mesenchymal stem cells   -   -   -   -   1件:
97 
 84   Adipose-cord mesenchymal stromal cells (a-mscs)   -   -   -   -   1件:
97 
 85   Aeb071   -   -   -   -   1件:
97 
 86   Ag011   -   -   -   -   1件:
97 
 87   Ag011 - capsules   -   -   -   -   1件:
97 
 88   Ag011 - enema   -   -   -   -   1件:
97 
 89   Ajg501   -   -   -   -   1件:
97 
 90   Ajg511   -   -   -   -   1件:
97 
 91   Ajm300   -   -   -   -   1件:
97 
 92   Aldesleukin   Aldesleukin   D00748   3件: IL2RA, IL2RB, IL2RG   14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor   3件:
49,
65,
97 
 93   Alicaforsen   Alicaforsen   -   -   -   2件:
96,
97 
 94   Alkaline phosphatase   Alkaline Phosphatase   -   -   -   3件:
46,
97,
172 
 95   Allopurinol   Allopurinol   D00224   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97 
 96   Aloasc   -   -   -   -   1件:
97 
 97   Aloe   Aloe Vera Leaf   -   -   -   1件:
97 
 98   Aloe barbadensis miller   Aloe Vera Leaf   -   -   -   1件:
97 
 99   Alth12-1:4   -   -   -   -   1件:
97 
 100   Alth12-2:4   -   -   -   -   1件:
97 
 101   Amg 181   -   -   -   -   2件:
96,
97 
 102   Amgevita 40mg solution for injection   -   -   -   -   2件:
96,
97 
 103   Aminosalicylic acid   Aminosalicylic Acid   D00162   -   -   2件:
96,
97 
 104   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 105   Amoxicillin and tetracycline   Amoxicillin, Tetracycline   D00201, D00229, D02925, D07452   -   -   1件:
97 
 106   Amoxicillin, metronidazole and tetracycline   Amoxicillin, Metronidazole, Tetracycline   D00201, D00229, D00409, D02925, D05016, D05017, D07452   -   -   1件:
97 
 107   And (andrographolide)   Andrographolide   -   -   -   1件:
97 
 108   Andosan   -   -   -   -   2件:
96,
97 
 109   Andrographis paniculata   -   -   -   -   1件:
97 
 110   Andrographis paniculata (ethanol extract)   Ethanol   D00068, D02798, D04855, D06542   -   -   1件:
97 
 111   Andrographolide   Andrographolide   -   -   -   1件:
97 
 112   Anrukinzumab   Anrukinzumab   D08857   1件: IL13   8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation   1件:
97 
 113   Anti cd3   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 114   Anti cd3 monoclonal antibody   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
97 
 115   Anti tnf therapy including infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 116   Anti-cd3   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 117   Anti-cd3 monoclonal antibody   Muromonab   D05092   3件: CD3D, CD3E, CD3G   11件: Chagas disease (American trypanosomiasis), Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 118   Anti-ip-10 antibody   -   -   -   -   1件:
97 
 119   Anti-madcam antibody   -   -   -   -   2件:
96,
97 
 120   Anti-tnf discontinuation: physiological saline solution   -   -   -   -   2件:
96,
97 
 121   Anti-tnf drug   -   -   -   -   2件:
96,
97 
 122   Anti-tnf therapy   -   -   -   -   3件:
46,
96,
97 
 123   Anti-tnf: infliximab (infusion)   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 124   Anti-tnf:adalimumab (subcutaneus)   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 125   Antibiotic cocktail   -   -   -   -   1件:
97 
 126   Aodg (apigenin-7-o-glucuronide)   Apigenin   -   -   -   1件:
97 
 127   Apd334   -   -   -   -   4件:
93,
96,
97,
269 
 128   Apigenin   Apigenin   -   -   -   1件:
97 
 129   Apixaban   Apixaban   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97 
 130   Apixaban 2.5 milligram   Apixaban   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97 
 131   Apremilast   Apremilast   D08860   4件: PDE4A, PDE4B, PDE4C, PDE4D   5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway   5件:
46,
50,
56,
97,
271 
 132   Apriso 0.375g er cap   -   -   -   -   1件:
97 
 133   Apriso 375 mg extended-release capsules   -   -   -   -   1件:
97 
 134   Apvo210   -   -   -   -   1件:
97 
 135   Aquamin®   -   -   -   -   1件:
97 
 136   Asacol   Mesalazine   D00377   -   -   1件:
97 
 137   Asacol (mesalamine)   Mesalazine   D00377   -   -   1件:
97 
 138   Asacol (mesalamine) delayed-release tablets   Mesalazine   D00377   -   -   1件:
97 
 139   Asacol 400 mg   -   -   -   -   1件:
97 
 140   Asacol 400 mg (mesalamine)   Mesalazine   D00377   -   -   1件:
97 
 141   Asacol 400 mg tablet   Mesalazine   D00377   -   -   1件:
97 
 142   Asacol 800 mg (mesalamine)   Mesalazine   D00377   -   -   1件:
97 
 143   Asacol 800 mg tablet   Mesalazine   D00377   -   -   1件:
97 
 144   Asacol delayed release tablets   Mesalazine   D00377   -   -   1件:
97 
 145   Asacol delayed-release tablets   Mesalazine   D00377   -   -   1件:
97 
 146   Asacol tablet   Mesalazine   D00377   -   -   1件:
97 
 147   Asacol®   -   -   -   -   1件:
97 
 148   Asacol® 400 mg   -   -   -   -   1件:
97 
 149   Ascorbic acid   Ascorbic acid   D00018   -   -   2件:
10,
97 
 150   Asp3291   -   -   -   -   1件:
97 
 151   Aspergillus oryzae   Aspergillus oryzae   -   -   -   1件:
97 
 152   Ast-120   -   -   -   -   2件:
96,
97 
 153   Atl-2502   ATL-2502   -   -   -   1件:
97 
 154   Avonex   Water   D00001   -   -   2件:
13,
97 
 155   Avx 470   -   -   -   -   1件:
97 
 156   Azafor 50mg   -   -   -   -   1件:
97 
 157   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 158   Azathioprine (aza)   Azathioprine   D00238, D03033   -   -   2件:
19,
97 
 159   Azathioprine (aza) or 6-mercaptopurine (6-mp)   Mercaptopurine, Azathioprine   D00161, D00238, D03033, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 160   Azathioprine and allopurinol   Allopurinol, Azathioprine   D00224, D00238, D03033   1件: XDH   5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   1件:
97 
 161   Azathioprine or 6-mercaptopurine   Mercaptopurine, Azathioprine   D00161, D00238, D03033, D04931   1件: HPRT1   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   2件:
96,
97 
 162   Azatioprina   Azathioprine   D00238, D03033   -   -   3件:
13,
96,
97 
 163   B: 2 dosis   -   -   -   -   1件:
97 
 164   Bacteriotherapy   -   -   -   -   2件:
96,
97 
 165   Balsalazide   Balsalazide   D02715, D07488   -   -   1件:
97 
 166   Balsalazide disodium   Balsalazide   D02715, D07488   -   -   1件:
97 
 167   Baminercept   Baminercept   D08866   1件: LTB   3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis   4件:
13,
46,
53,
97 
 168   Bascial prescription plus or minus herbs depend on symptoms   -   -   -   -   1件:
97 
 169   Basiliximab   Basiliximab   D03058   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   6件:
2,
50,
65,
97,
222,
228 
 170   Bbt-401-1s, multiple doses   -   -   -   -   1件:
97 
 171   Bbt-401-1s, single dose   -   -   -   -   1件:
97 
 172   Beclometasone dipropionate   Beclomethasone dipropionate   D00689, D07495   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 173   Beclomethasone dipropionate   Beclomethasone dipropionate   D00689, D07495   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
97,
98 
 174   Beclomethasone diproprionate   -   -   -   -   1件:
97 
 175   Berberine   Berberine   D00092   -   -   1件:
97 
 176   Berberine chloride   Berberine, Chloride ion   D00092   -   -   1件:
97 
 177   Bertilimumab   -   -   -   -   2件:
97,
162 
 178   Beta-1,3/1,6-d-glucan   -   -   -   -   1件:
97 
 179   Bg9418 (interferon beta-1a)   Human interferon beta, Interferon beta-1a, interferon beta   D04554   2件: IFNAR1, IFNAR2   17件: Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway   2件:
13,
97 
 180   Bg9924   -   -   -   -   2件:
46,
97 
 181   Bi 655130   -   -   -   -   3件:
37,
96,
97 
 182   Biap   -   -   -   -   2件:
46,
97 
 183   Bifidobacterium infantis   Bifidobacterium longum infantis   -   -   -   2件:
96,
97 
 184   Bifidobacterium infantis 35624   Bifidobacterium longum infantis   -   -   -   2件:
96,
97 
 185   Bimekizumab   Bimekizumab   D11550   2件: IL17A, IL17F   5件: Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Th17 cell differentiation   3件:
46,
97,
271 
 186   Bio-enhanced curcumin soft gelatin capsule   Curcumin, Gelatin   D00115, D06892   -   -   1件:
97 
 187   Biologically active human fecal microbiota   -   -   -   -   1件:
97 
 188   Biopsies   -   -   -   -   1件:
97 
 189   Biosimilar   -   -   -   -   4件:
46,
96,
97,
271 
 190   Biosimilar infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 191   Bitter candytuft fresh plant extract   -   -   -   -   1件:
97 
 192   Bitterschleifenblume-ganzpflanze 1,5ml/10ml   -   -   -   -   1件:
97 
 193   Bl-7040   -   -   -   -   1件:
97 
 194   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 195   Blood samples   -   -   -   -   8件:
13,
41,
46,
51,
61,
97,
227,
271 
 196   Bms-188667   bms-188667   D03203   2件: CD80, CD86   12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis   6件:
46,
49,
65,
96,
97,
271 
 197   Bms-986165   -   -   -   -   3件:
49,
96,
97 
 198   Bms-986166   -   -   -   -   1件:
97 
 199   Bms-986184   -   -   -   -   1件:
97 
 200   Boulardii   -   -   -   -   2件:
96,
97 
 201   Bovine intestinal alkaline phosphatase (biap)   Alkaline Phosphatase   -   -   -   1件:
97 
 202   Bovine-calf alkaline phosphatase (biap)   Alkaline Phosphatase   -   -   -   1件:
97 
 203   Bovine-calf alkaline phosphatase biap   Alkaline Phosphatase   -   -   -   1件:
97 
 204   Brazikumab   -   -   -   -   2件:
96,
97 
 205   Bt-11 (1000 mg)   -   -   -   -   1件:
97 
 206   Bt-11 (500 mg)   -   -   -   -   1件:
97 
 207   Bt-11 active   -   -   -   -   2件:
96,
97 
 208   Budenofalk 2mg rectal foam   -   -   -   -   1件:
97 
 209   Budenofalk 3mg   -   -   -   -   2件:
93,
97 
 210   Budenofalk rectal foam   -   -   -   -   1件:
97 
 211   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 212   Budesonide (6 mg)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 213   Budesonide (9 mg)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 214   Budesonide 6 mg capsules, hard (bux-pvii prototype)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 215   Budesonide 9 mg capsules, hard (bux-pv)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 216   Budesonide 9 mg capsules, hard (bux-pvii prototype)   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 217   Budesonide mmx 6 mg tablet   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 218   Budesonide mmx®   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 219   Budesonide mmx® 6 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 220   Budesonide mmx® 9 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 221   Budesonide-mmx   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 222   Budesonide-mmx®   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 223   Budesonide-mmx® 6 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 224   Budesonide-mmx® 9 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 225   Budesonide-mmx™   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 226   Butanoic acid   Butyric Acid   D05866   -   -   3件:
34,
51,
97 
 227   Caffeine   Caffeine   D00528, D01453   11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A   22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
2,
6,
46,
78,
96,
97 
 228   Calcitonin nasal spray (salmon)   -   -   -   -   2件:
96,
97 
 229   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 230   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 231   Cannabis   Medical Cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 232   Cannabis, medical   Medical Cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 233   Carbon   Activated charcoal   D03251   -   -   7件:
6,
46,
85,
86,
96,
97,
298 
 234   Carbon dioxide   Activated charcoal, Carbon dioxide   D00004, D03251   -   -   1件:
97 
 235   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 236   Carrageenan   -   -   -   -   1件:
97 
 237   Carvi extractum fluidum   -   -   -   -   1件:
97 
 238   Casein   Casein   -   -   -   1件:
97 
 239   Casein glycomacropeptide (cgmp)   Casein, Cyclic GMP   -   -   -   1件:
97 
 240   Cat-354   -   -   -   -   1件:
97 
 241   Catridecacog   Catridecacog   D10532   -   -   2件:
97,
288 
 242   Cb-01-02   -   -   -   -   1件:
97 
 243   Cb-01-05-mmx   -   -   -   -   1件:
97 
 244   Ceftriaxone   Ceftriaxone   D00924, D07659   -   -   3件:
2,
6,
97 
 245   Cefuroxime   Cefuroxime   D00262, D00914, D00915, D03431   -   -   1件:
97 
 246   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 247   Cgmp   Cyclic GMP   -   -   -   1件:
97 
 248   Cgmp protein   Cyclic GMP   -   -   -   1件:
97 
 249   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 250   Chlorogenic acid   Chlorogenic Acid   -   -   -   1件:
97 
 251   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 252   Ciclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   13件:
26,
46,
49,
50,
53,
55,
60,
61,
97,
222,
226,
228,
269 
 253   Cimzia   Certolizumab pegol   D03441   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
46,
96,
97,
271 
 254   Ciprofloxacin   Ciprofloxacin   D00186, D02216   -   -   5件:
2,
60,
96,
97,
299 
 255   Cla (chlorogenic acid)   Chlorogenic Acid   -   -   -   1件:
97 
 256   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 257   Clipper   -   -   -   -   1件:
97 
 258   Clotrimazole   Clotrimazole   D00282   -   -   1件:
97 
 259   Cnto148   -   -   -   -   2件:
46,
97 
 260   Coamoxiclav   -   -   -   -   1件:
97 
 261   Cobitolimod   Cobitolimod   -   -   -   1件:
97 
 262   Coffee coal   -   -   -   -   1件:
97 
 263   Colal-pred   -   -   -   -   1件:
97 
 264   Colal-pred®   -   -   -   -   1件:
97 
 265   Coltect   -   -   -   -   1件:
97 
 266   Combination oral budesonide and rectal hydrocortisone   Budesonide, Hydrocortisone acetate   D00165, D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 267   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 268   Corticosteroids   -   -   -   -   9件:
41,
46,
49,
64,
97,
164,
220,
296,
300 
 269   Corticosteroids only   -   -   -   -   1件:
97 
 270   Corticosteroids then mesalamine   Mesalazine   D00377   -   -   1件:
97 
 271   Cortimentmmx 9 mg   -   -   -   -   1件:
97 
 272   Cosmofer   -   -   -   -   2件:
96,
97 
 273   Cosmofer 50mg/ml solution for infusion or injection   -   -   -   -   2件:
96,
97 
 274   Cotrimoxazole   -   -   -   -   2件:
85,
97 
 275   Cp- 690 550   -   -   -   -   1件:
97 
 276   Cp-690,500 5 mg   -   -   -   -   1件:
97 
 277   Cp-690,550   -   -   -   -   4件:
46,
96,
97,
271 
 278   Cp-690,550 10 mg   -   -   -   -   1件:
97 
 279   Cp-690,550-10   -   -   -   -   3件:
46,
96,
97 
 280   Cp690,550   -   -   -   -   2件:
46,
97 
 281   Cs (corticosteroids) only   -   -   -   -   1件:
97 
 282   Ct-p13   -   -   -   -   4件:
46,
96,
97,
271 
 283   Curcumin   Curcumin   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299 
 284   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 285   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 286   Cyclosporine (usan)   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   1件:
97 
 287   Cyclosporine vs infliximab   Ciclosporin, Infliximab   D00184, D02598   6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, TNF   80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Dopaminergic synapse, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Glucagon signaling pathway, Glutamatergic synapse, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Long-term potentiation, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Renin secretion, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Wnt signaling pathway, Yersinia infection, cGMP-PKG signaling pathway, mTOR signaling pathway   1件:
97 
 288   Cycol   -   -   -   -   1件:
97 
 289   Cycol™   -   -   -   -   1件:
97 
 290   D-proline   D-Proline, Proline   D00035   -   -   1件:
97 
 291   Daclizumab   Daclizumab   D03639   1件: IL2RA   11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   7件:
13,
56,
60,
65,
97,
283,
284 
 292   Dacortin   dacortin   D00068, D02798, D04855, D06542   -   -   2件:
46,
97 
 293   Dand (14-deoxyandrographolide)   -   -   -   -   1件:
97 
 294   Ddand (14-deoxy-11,12-didehydroandrographolide)   -   -   -   -   1件:
97 
 295   Decortin   decortin   D00068, D02798, D04855, D06542   -   -   5件:
46,
96,
97,
113,
145 
 296   Decortin h 1 mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
97 
 297   Decortin h 10mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
97 
 298   Decortin h 20mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
97 
 299   Decortin h 50 mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
97 
 300   Decortin h 5mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
97 
 301   Dekristol   -   -   -   -   2件:
13,
97 
 302   Deligoparin   -   -   -   -   1件:
97 
 303   Delmitide acetate   Acetate   -   -   -   1件:
97 
 304   Deltacortene   -   -   -   -   1件:
97 
 305   Dersalazine   Dersalazine   -   -   -   1件:
97 
 306   Dersalazine sodium   Dersalazine   -   -   -   1件:
97 
 307   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 308   Dexamethasone 21-phosphate   Dexamethasone, Phosphate ion   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 309   Dextran   Dextran   D00060   -   -   5件:
2,
62,
79,
96,
97 
 310   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 311   Dims0150   -   -   -   -   1件:
97 
 312   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 313   E. coli nissle   -   -   -   -   1件:
97 
 314   Ecologic 825   -   -   -   -   1件:
97 
 315   Egf enema   -   -   -   -   1件:
97 
 316   Eicosapentaenoic acid   Icosapent   D08061   -   -   5件:
49,
96,
97,
296,
297 
 317   Emea/h/c/000481   -   -   -   -   1件:
97 
 318   Encapsulated faecal microbiota   -   -   -   -   1件:
97 
 319   Encapsulated faecal microbiota filtrate   -   -   -   -   1件:
97 
 320   Entecavir   Entecavir   D04008, D07896   -   -   5件:
46,
56,
96,
97,
271 
 321   Entocort ec® 3 mg   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 322   Entocort® cr   -   -   -   -   1件:
97 
 323   Entyvio   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   2件:
96,
97 
 324   Entyvio 300mg   Vedolizumab   D08083   2件: ITGA4, ITGB7   15件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection   1件:
97 
 325   Epaxal berna (virosomal hepatitis a vaccine)   Hepatitis A Vaccine   -   -   -   2件:
96,
97 
 326   Epidermal growth factor   -   -   -   -   1件:
97 
 327   Epidermal growth factor enema   -   -   -   -   1件:
97 
 328   Ergocalciferol   Ergocalciferol   D00187   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   5件:
46,
84,
96,
97,
299 
 329   Ethanol   Ethanol   D00068, D02798, D04855, D06542   -   -   3件:
97,
279,
280 
 330   Etrasimod   Etrasimod   D10930   5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5   3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
97 
 331   Etrolizumab   Etrolizumab   D09901   1件: ITGB7   11件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cell adhesion molecules (CAMs), Dilated cardiomyopathy (DCM), ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer   2件:
96,
97 
 332   Etrozulimab   -   -   -   -   1件:
97 
 333   Eubacterial spores, purified suspension, encapsulated   -   -   -   -   1件:
97 
 334   Exposure to golimumab   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 335   Faecal microbiota transplantation   -   -   -   -   2件:
96,
97 
 336   Fe 999301   -   -   -   -   2件:
96,
97 
 337   Fecal microbial transplant   -   -   -   -   2件:
96,
97 
 338   Fecal microbial transplantation   -   -   -   -   2件:
96,
97 
 339   Fecal microbiota   -   -   -   -   2件:
13,
97 
 340   Fecal microbiota enema   -   -   -   -   1件:
97 
 341   Fecal microbiota transplant   -   -   -   -   2件:
96,
97 
 342   Fecal microbiota transplantation   -   -   -   -   5件:
2,
66,
94,
96,
97 
 343   Fecal microbiota transplantation (fmt)   -   -   -   -   2件:
96,
97 
 344   Fecal microbiota transplantation (fmt), openbiome   -   -   -   -   1件:
97 
 345   Ferric carboxymaltose   Ferric carboxymaltose   D08920   -   -   4件:
86,
96,
97,
299 
 346   Ferrous sulphate   -   -   -   -   2件:
96,
97 
 347   Filgotinib   Filgotinib   D10871   1件: JAK1   26件: EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis   6件:
46,
53,
96,
97,
222,
271 
 348   Fitc-adalimumab   Adalimumab   D02597   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 349   Flagyl   Metronidazole   D00409, D05016, D05017   -   -   2件:
96,
97 
 350   Flaxseed lignan-enriched complex (flc)   -   -   -   -   1件:
97 
 351   Flixabi   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 352   Fluorescein   Fluorescein   D01261, D02024   -   -   2件:
19,
97 
 353   Flupentixol   Flupentixol   D01044   2件: DRD1, DRD2   11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
97 
 354   Fmt infusions   -   -   -   -   1件:
97 
 355   Fosfomycin   Fosfomycin   D00925, D02187, D02188, D04253   -   -   2件:
96,
97 
 356   Fp-110   -   -   -   -   1件:
97 
 357   Fp-cya-050   -   -   -   -   1件:
97 
 358   Fp-cya-053   -   -   -   -   1件:
97 
 359   Freeze-dried black raspberry powder   Raspberry   -   -   -   1件:
97 
 360   G321605   -   -   -   -   3件:
85,
96,
97 
 361   Ganciclovir   Ganciclovir   D00333, D04301   -   -   3件:
28,
60,
97 
 362   Gastro-resistant phosphatidylcholine granules   -   -   -   -   1件:
97 
 363   Gb004   -   -   -   -   1件:
97 
 364   Ged-0301   -   -   -   -   2件:
96,
97 
 365   Ged-0507-34-levo   -   -   -   -   1件:
97 
 366   Ged-0507-34-levo 160 mg   -   -   -   -   1件:
97 
 367   Ged-0507-34-levo 80 mg   -   -   -   -   1件:
97 
 368   Ged0507   -   -   -   -   1件:
97 
 369   Gelatin   Gelatin   D00115, D06892   -   -   4件:
47,
78,
97,
269 
 370   Gi-270384   -   -   -   -   1件:
97 
 371   Glpg0974   GLPG0974   -   -   -   1件:
97 
 372   Glpg1205   GLPG1205   -   -   -   3件:
85,
96,
97 
 373   Glutamine   L-Glutamine   D00015   -   -   6件:
87,
96,
97,
113,
245,
299 
 374   Glycyrrhiza   Glycyrrhiza glabra   -   -   -   1件:
97 
 375   Glycyrrhiza glabra   Glycyrrhiza glabra   -   -   -   1件:
97 
 376   Glycyrrhiza glabra root   Glycyrrhiza glabra   -   -   -   1件:
97 
 377   Golimumab   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   5件:
46,
84,
96,
97,
271 
 378   Golimumab (glm)   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 379   Golimumab (optimization)   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 380   Golimumab 1 mg per kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 381   Golimumab 100 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
46,
97 
 382   Golimumab 2 mg per kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 383   Golimumab 200 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 384   Golimumab 4 mg per kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 385   Golimumab 400 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 386   Golimumab 50 mg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
46,
97 
 387   Golimumab 50 mg in patients <80 kg and golimumab 100 mg in patients >80 kg   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 388   Golimumab dose 1   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 389   Golimumab dose 2   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 390   Golimumab prefilled syringe   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 391   Golimumab treatment optimization.   Golimumab   D04358   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 392   Gralise   Gabapentin   D00332   5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1   9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), GABAergic synapse, Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle   2件:
97,
226 
 393   Granulated mesalamine   Mesalazine   D00377   -   -   1件:
97 
 394   Grapefruit   Grapefruit   -   -   -   5件:
6,
46,
50,
83,
97 
 395   Group 1- control diet   -   -   -   -   1件:
97 
 396   Group 2- ucd diet   -   -   -   -   1件:
97 
 397   Gs-4875   -   -   -   -   1件:
97 
 398   Gs-5745   GS-5745   -   -   -   2件:
46,
97 
 399   Gs-5745 iv   GS-5745   -   -   -   1件:
97 
 400   Gs-5745 sc   GS-5745   -   -   -   1件:
97 
 401   Gs-6034   -   -   -   -   3件:
46,
96,
97 
 402   Gsk1399686   -   -   -   -   1件:
97 
 403   Gsk1605786   -   -   -   -   2件:
96,
97 
 404   Gsk1605786a   -   -   -   -   2件:
96,
97 
 405   Gsk2586184 400mg   -   -   -   -   1件:
97 
 406   Gsk2831781   -   -   -   -   1件:
97 
 407   Gsk2982772   -   -   -   -   2件:
46,
97 
 408   Gsk2982772a, where a denotes the free base   -   -   -   -   2件:
46,
97 
 409   Guaiazulene   Guaiazulen   -   -   -   1件:
97 
 410   Guselkumab   Guselkumab   D10438   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   3件:
37,
96,
97 
 411   Guselkumab dose 1   Guselkumab   D10438   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   1件:
97 
 412   Guselkumab dose 2   Guselkumab   D10438   1件: IL23A   9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis   1件:
97 
 413   Gwp42003   -   -   -   -   1件:
97 
 414   He3286   HE3286   -   -   -   2件:
46,
97 
 415   Hemay007   -   -   -   -   1件:
97 
 416   Hepatitis a vaccine   Hepatitis A Vaccine   -   -   -   3件:
46,
96,
97 
 417   Herbal treatment (sa100)   -   -   -   -   1件:
97 
 418   Hextend   Hydroxyethyl Starch   D03335   -   -   2件:
96,
97 
 419   Hgd40   -   -   -   -   1件:
97 
 420   Hgs1025   -   -   -   -   1件:
97 
 421   High dose   -   -   -   -   1件:
97 
 422   Hmpl-004   -   -   -   -   1件:
97 
 423   Hmpl-004 tablet   -   -   -   -   1件:
97 
 424   Hmpl004-6599   -   -   -   -   2件:
96,
97 
 425   Hum291   -   -   -   -   2件:
96,
97 
 426   Human anti-tnf-alpha monoclonal antibody   -   -   -   -   2件:
46,
97 
 427   Humira   Isopropyl alcohol   D00137   -   -   6件:
46,
84,
96,
97,
269,
271 
 428   Humira 40 mg solution for injection in pre-filled syringe   Isopropyl alcohol   D00137   -   -   3件:
46,
96,
97 
 429   Humira 40 mg solution for injection in pre-filled syringes   Isopropyl alcohol   D00137   -   -   1件:
97 
 430   Humira 40 mg/0.8 ml solution for injection for paediatric use   Isopropyl alcohol   D00137   -   -   1件:
97 
 431   Humira 40mg solution for injection   -   -   -   -   2件:
96,
97 
 432   Humira®   -   -   -   -   4件:
46,
96,
97,
271 
 433   Hyaluronate   Hyaluronic acid   D08043   -   -   2件:
53,
97 
 434   Hydrocortisone   Hydrocortisone acetate   D00165   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299 
 435   Hydrocortisone sodium succinate   Hydrocortisone acetate   D00165   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
97 
 436   Hydrogen   Hydrogen   -   -   -   5件:
5,
6,
17,
97,
226 
 437   Hydroxide   Hydroxide ion   -   -   -   4件:
46,
96,
97,
284 
 438   Ibd98-m   -   -   -   -   1件:
97 
 439   Ibd98-m delayed-release capsules   -   -   -   -   1件:
97 
 440   Iberogast n   -   -   -   -   1件:
97 
 441   Im90838   -   -   -   -   1件:
97 
 442   Impact   Topramezone   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299 
 443   Imu-838   -   -   -   -   1件:
97 
 444   Imuran   Azathioprine   D00238, D03033   -   -   2件:
96,
97 
 445   Imurek 25mg filmtabletten   -   -   -   -   1件:
97 
 446   Imurek 50mg filmtabletten   -   -   -   -   1件:
97 
 447   Imurel   -   -   -   -   2件:
96,
97 
 448   Inflectra   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 449   Infliximab   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 450   Infliximab (ifx)   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   1件:
97 
 451   Infliximab 10 mg/kg   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   3件:
46,
96,
97 
 452   Infliximab 5 mg/kg   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   2件:
96,
97 
 453   Infliximab [infliximab biosimilar 3]   Infliximab   D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   4件:
37,
46,
96,
97 
 454   Infliximab and adalimumab   Adalimumab, Infliximab   D02597, D02598   1件: TNF   61件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway,